glp-1 drug class Classification of glucagon-like peptide-1 receptor agonists Data from: New GLP-1 Guidelines for Type

Leger B, Derave W, De Bock K, Hespel P, Russell AP (2008) Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation

When Longer Use May Be Appropriate Some people may need longer support, especially if oxidative stress is high

Transdermal Semaglutide Administration in Mice: Reduces Body Weight by Suppressing Appetite and Enhancing Metabolic Rate

Genes Cells (1999) 4(6):33951.10.1046/j.1365-2443.1999.00263.x 133 YasukawaHMisawaHSakamotoHMasuharaMSasakiAWakiokaTet alThe JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

See section 7 below for a discussion of agents presently under study for gout